Precision medicine is expected to shape the future of health care: it aims at preventing diseases by tailoring therapies based on the unique genetic background of an individual, environment and lifestyle habits. This emerging approach holds great potential for enhancing human health and optimizing the evolution and clinical use of medications. Despite of it, the obstacles to face are preventing science and technology to progress. The subject attracted huge attention from the medical and scientific communities, including scholars in the field of biomedical research. On the other hand, the literature regarding managerial perspective and the impact of this new and emerging approach on the healthcare system, is very scarce, if not absent. Different precision medicine initiatives have been implemented in the world in the past years: the most important is the “Precision medicine Initiative”, announced in 2015 by the former president of USA Barack Obama. The goal, he said, was “delivering the right treatment at the right time, every time, to the right person”. The vision behind this approach is that healthcare should become proactive instead of reactive, permitting people to live healthiers and longer lives. The aim of this study is to analyze the impact of precision medicine on the whole health care pipeline, from research to care delivery. To present a detailed overview of the current situation of precision medicine, we have conducted a quantitative analysis, administering a survey to healthcare professionals. The questionnaire was filled out by managerial and medical professionals, belonging to different hospitals. The project has been conducted together with a colleague: we will both address the same topic but we will analyze the results according to different research questions. Key words: precision medicine, life sciences, business model, healthcare system, targeted therapy.
È ampiamente ritenuto che medicina di precisione stia alterando il futuro dell'assistenza sanitaria: essa mira a prevenire le malattie adattando le terapie basandosi sullo sfondo genetico unico di un individuo, sull’ambiente in cui vive e sulle abitudini di vita. Questo approccio emergente offre un grande potenziale per migliorare la salute umana , ottimizzare l'evoluzione e l'uso clinico dei farmaci. Nonostante ciò, gli ostacoli da affrontare sono molti e impediscono alla scienza e alla tecnologia di progredire. L'argomento ha attirato grande attenzione da parte delle comunità mediche e scientifiche, inclusi studiosi nel campo della ricerca biomedica. D'altra parte, la letteratura riguardante la prospettiva manageriale e l'impatto di questo nuovo approccio emergente sul sistema sanitario, è molto scarsa, se non addirittura assente. Diverse iniziative di medicina di precisione sono state implementate nel mondo negli ultimi anni: la più importante è la "Precision medicine Initiative", annunciata nel 2015 dall'ex presidente degli Stati Uniti Barack Obama. L'obiettivo, dell’ex-presidente era "consegnare il trattamento giusto al momento giusto, ogni volta, alla persona giusta". La visione dietro questo approccio è che l'assistenza sanitaria dovrebbe diventare proattiva anziché reattiva, permettendo alle persone di una vita più lunga e in salute. Lo scopo di questo studio è di analizzare l'impatto della medicina di precisione sull'intera catena sanitaria, dalla ricerca all’assistenza e cura dei pazienti. Per presentare una panoramica dettagliata della situazione attuale della medicina di precisione, abbiamo condotto un'analisi quantitativa, creando un sondaggio per gli operatori sanitari. Il questionario è stato compilato da professionisti manageriali (direttori sanitari, generali ed amministrativi) e medici appartenenti a diversi ospedali. Il progetto è stato condotto insieme ad una collega: affronteremo lo stesso argomento, ma analizzeremo i risultati in base alle diverse domande di ricerca. Parole chiave: medicina di precisione, scienze della vita, modello di business, sistema sanitario, terapia mirata.
Towards a new era of medicine: the strategic impact of Precision Medicine on the healthcare system
PODRATZ, LAURA
2018/2019
Abstract
Precision medicine is expected to shape the future of health care: it aims at preventing diseases by tailoring therapies based on the unique genetic background of an individual, environment and lifestyle habits. This emerging approach holds great potential for enhancing human health and optimizing the evolution and clinical use of medications. Despite of it, the obstacles to face are preventing science and technology to progress. The subject attracted huge attention from the medical and scientific communities, including scholars in the field of biomedical research. On the other hand, the literature regarding managerial perspective and the impact of this new and emerging approach on the healthcare system, is very scarce, if not absent. Different precision medicine initiatives have been implemented in the world in the past years: the most important is the “Precision medicine Initiative”, announced in 2015 by the former president of USA Barack Obama. The goal, he said, was “delivering the right treatment at the right time, every time, to the right person”. The vision behind this approach is that healthcare should become proactive instead of reactive, permitting people to live healthiers and longer lives. The aim of this study is to analyze the impact of precision medicine on the whole health care pipeline, from research to care delivery. To present a detailed overview of the current situation of precision medicine, we have conducted a quantitative analysis, administering a survey to healthcare professionals. The questionnaire was filled out by managerial and medical professionals, belonging to different hospitals. The project has been conducted together with a colleague: we will both address the same topic but we will analyze the results according to different research questions. Key words: precision medicine, life sciences, business model, healthcare system, targeted therapy.È consentito all'utente scaricare e condividere i documenti disponibili a testo pieno in UNITESI UNIPV nel rispetto della licenza Creative Commons del tipo CC BY NC ND.
Per maggiori informazioni e per verifiche sull'eventuale disponibilità del file scrivere a: unitesi@unipv.it.
https://hdl.handle.net/20.500.14239/8764